Biotech

All Articles

Nuvation halts BET prevention after taking into consideration period 1 data

.After having a look at period 1 data, Nuvation Bio has actually decided to stop deal with its own o...

' Professional intuitiveness' led FDA experts to support Zevra's uncommon health condition med

.Zevra Therapies' rare health condition medicine seems to be to become on the path to confirmation t...

Pfizer takes $230M struck after axing stopped working DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has actually gone a $230 ...

AC Immune sees 'landmark' prospective in Alzheimer's medicine data

.After greater than twenty years of work with neurodegenerative illness, Swiss biotech air condition...

GSK loses ph. 2 HPV injection over shortage of best-in-class prospective

.GSK has actually junked a stage 2 individual papillomavirus (HPV) injection from its own pipeline a...

OS Therapies refiles $6M IPO to finance HER2 drug, preclinical ADCs

.OS Therapies will detail on the NYSE American inventory exchange today by means of a $6.4 million I...

ALX's fizzling CD47 response fee delivers stock spiraling down

.ALX Oncology's period 2 stomach cancer reaction fee has weakened. After seeing its CD47 blocker sim...

Ionis centers eye illness coming from targets of Roche-partnered possibility after data let down

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has actually fallen short of expectatio...

Biogen's CEO pointed out no risky sell 2023. He prepares to be bold

.While Biogen's pharma peers are actually looking for late-stage possessions with little danger, CEO...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech seeking a pipe after it junked its lead prope...